WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INO

Based on 3 analysts offering 12 month price targets for Inovio Pharmaceuticals Inc

Min Forecast
$2.50+101.61%
Avg Forecast
$3.17+155.4%
Max Forecast
$4.00+222.58%

Should I buy or sell INO stock?

Based on 3 analysts offering ratings for Inovio Pharmaceuticals Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although INO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates INO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their INO stock forecasts and price targets.

INO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-13
lockedlocked$00.00+00.00%2026-08-03
lockedlocked$00.00+00.00%2026-06-01

1 of 1

Forecast return on equity

Is INO forecast to generate an efficient return?

Company
1,122.9%
Industry
21.25%
Market
168.71%
INO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INO forecast to generate an efficient return on assets?

Company
99.38%
Industry
23.75%
INO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INO earnings per share forecast

What is INO's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$0.81
Avg 2 year Forecast
-$0.44
Avg 3 year Forecast
-$0.11

INO revenue forecast

What is INO's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$673.3k
Avg 2 year Forecast
$51.1M
Avg 3 year Forecast
$79.9M

INO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INO$1.24$3.17+155.40%Strong Buy
ENGN$1.91$6.70+250.79%Hold
LENZ$4.07$23.50+477.40%Strong Buy
VTVT$31.80$49.50+55.66%Strong Buy
PMN$14.01$47.80+241.18%Strong Buy
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Forecast FAQ

Is Inovio Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: INO) stock is to Strong Buy INO stock.

Out of 3 analysts, 2 (66.67%) are recommending INO as a Strong Buy, 0 (0%) are recommending INO as a Buy, 1 (33.33%) are recommending INO as a Hold, 0 (0%) are recommending INO as a Sell, and 0 (0%) are recommending INO as a Strong Sell.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.

What is INO's earnings growth forecast for 2026-2028?

(NASDAQ: INO) Inovio Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.22%.

Inovio Pharmaceuticals's earnings in 2026 is -$67,427,048.On average, 5 Wall Street analysts forecast INO's earnings for 2026 to be -$84,237,958, with the lowest INO earnings forecast at -$99,302,976, and the highest INO earnings forecast at -$77,082,850. On average, 4 Wall Street analysts forecast INO's earnings for 2027 to be -$45,598,305, with the lowest INO earnings forecast at -$67,890,810, and the highest INO earnings forecast at -$22,799,153.

In 2028, INO is forecast to generate -$11,487,464 in earnings, with the lowest earnings forecast at -$11,146,252 and the highest earnings forecast at -$11,942,413.

What is INO's revenue growth forecast for 2026-2028?

(NASDAQ: INO) Inovio Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.

Inovio Pharmaceuticals's revenue in 2026 is $0.On average, 4 Wall Street analysts forecast INO's revenue for 2026 to be $69,621,375, with the lowest INO revenue forecast at $0, and the highest INO revenue forecast at $217,134,788. On average, 4 Wall Street analysts forecast INO's revenue for 2027 to be $5,284,957,338, with the lowest INO revenue forecast at $1,347,683,250, and the highest INO revenue forecast at $8,685,391,512.

In 2028, INO is forecast to generate $8,260,531,111 in revenue, with the lowest revenue forecast at $8,015,168,800 and the highest revenue forecast at $8,587,680,857.

What is INO's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: INO) forecast ROA is 99.38%, which is higher than the forecast US Biotechnology industry average of 23.75%.

What is INO's Price Target?

According to 3 Wall Street analysts that have issued a 1 year INO price target, the average INO price target is $3.17, with the highest INO stock price forecast at $4.00 and the lowest INO stock price forecast at $2.50.

On average, Wall Street analysts predict that Inovio Pharmaceuticals's share price could reach $3.17 by Aug 13, 2027. The average Inovio Pharmaceuticals stock price prediction forecasts a potential upside of 155.4% from the current INO share price of $1.24.

What is INO's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: INO) Inovio Pharmaceuticals's current Earnings Per Share (EPS) is -$0.91. On average, analysts forecast that INO's EPS will be -$0.81 for 2026, with the lowest EPS forecast at -$0.96, and the highest EPS forecast at -$0.75. On average, analysts forecast that INO's EPS will be -$0.44 for 2027, with the lowest EPS forecast at -$0.66, and the highest EPS forecast at -$0.22. In 2028, INO's EPS is forecast to hit -$0.11 (min: -$0.11, max: -$0.12).

What is INO's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: INO) forecast ROE is 1,122.9%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.